Development and Validation of a Stability-Indicating Ion-Pair RP-HPLC Method for Determination of Bethanechol with UV Detection: Application to Pharmaceutical Analysis

被引:0
作者
Zahra Jafari Azar
Minoo Afshar
机构
[1] Pharmaceutical Sciences Branch of Islamic Azad University,Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences
来源
Pharmaceutical Chemistry Journal | 2019年 / 53卷
关键词
bethanechol chloride; ion-pair RP-HPLC; UV detection; pharmaceutical preparations; stability-indicating method;
D O I
暂无
中图分类号
学科分类号
摘要
A rapid and stability indicating ion-pair RP-HPLC method was developed for estimation of bethanechol chloride (BC) in pharmaceutical preparations. The separation was achieved on a phenyl column using a mobile phase consisting of 0.05 M phosphate buffer (pH 6) – ethanol (98:2 v/v) mixture containing 0.56 mg/mL of sodium 1-heptanesulfonate. Quantitation was achieved with UV detection at 190 nm. In forced degradation studies, the drug was subjected to oxidation, hydrolysis, photolysis, and heat. The method was validated for specificity, selectivity, linearity, precision, accuracy, and robustness. The analytical procedure was found to be linear in a BC concentration range of 5.0 – 500.0 μg/mL (r2 = 0.9997). Precision was evaluated by replicate analysis in which%deviations from relative standard values of peak areas were found below 2.0. The recoveries obtained (99.0 – 102.0%) ensure the accuracy of the proposed method. Impurities as well as excipients were well resolved from the parent drug. Accordingly, the proposed validated procedure was proved to be suitable for routine and stability analysis of BC in pharmaceutical preparations.
引用
收藏
页码:376 / 382
页数:6
相关论文
共 40 条
  • [1] O’Rourke A(2013)undefined Ann. Otol., Rhinol., Laryngol. 122 481-486
  • [2] Weinberger P(2010)undefined Hepatogastroenterology 57 81-85
  • [3] Morrison M(2002)undefined J. Gastrointest. Surg. 6 281-283
  • [4] Araujo SE(2000)undefined Dis. Colon Rectum. 43 1359-1362
  • [5] Sousa MM(2015)undefined Radiother. Oncol. 115 253-256
  • [6] Caravatto PP(1998)undefined Am. J. Health-System Pharm. 55 1804-1809
  • [7] Habr-Gamai A(2013)undefined J. Anal. Methods Chem. 2013 353814-891
  • [8] Phillips R(2010)undefined J. Chromatogr. A 1217 882-152
  • [9] Carapeti EA(2010)undefined J. Pharm. Biomed. Anal. 51 146-129
  • [10] Kamm MA(2005)undefined J. Chromatogr. A 1097 124-486